Concepedia

Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study

Hyeon‐Jong Yang, Berto J. Bouma, Konstantinos Dimopoulos, Paul Khairy, Magalie Ladouceur, Koichiro Niwa, Matthias Greutmann, Markus Schwerzmann, Alexander C. Egbe, Giancarlo Scognamiglio,

International Journal of Cardiology · 2019 · 82 citations · 25 references

DOIFull text

Open access

Concepts

References

25

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

Jan Steffel, Peter Verhamme, Tatjana Potpara et al. · European Heart Journal · 2018 · 2.1K citations · Full text

, , +11

Task Force 1: the changing profile of congenital heart disease in adult life

Carole A. Warnes, Richard R. Liberthson, Gordon K. Danielson et al. · Journal of the American College of Cardiology · 2001 · 1.4K citations

, , +15

Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation

Hein Heidbüchel, Peter Verhamme, Marco Alings et al. · EP Europace · 2015 · 1.1K citations

, , +14

ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders

Francesco Rodeghiero, Alberto Tosetto, Thomas C. Abshire et al. · Journal of Thrombosis and Haemostasis · 2010 · 870 citations · Full text

, , +13

Measurement of Adherence in Pharmacy Administrative Databases: A Proposal for Standard Definitions and Preferred Measures

Lisa M. Hess, Marsha A. Raebel, Douglas A. Conner et al. · Annals of Pharmacotherapy · 2006 · 750 citations

, , +15